STABILE, ARMANDO
 Distribuzione geografica
Continente #
EU - Europa 3.333
AS - Asia 1.260
NA - Nord America 1.087
SA - Sud America 255
AF - Africa 31
OC - Oceania 2
Totale 5.968
Nazione #
IT - Italia 1.537
RU - Federazione Russa 1.126
US - Stati Uniti d'America 1.034
CN - Cina 392
SG - Singapore 342
BR - Brasile 192
HK - Hong Kong 152
NL - Olanda 137
SE - Svezia 135
VN - Vietnam 124
JP - Giappone 104
FR - Francia 77
DE - Germania 75
GB - Regno Unito 54
FI - Finlandia 48
IN - India 44
TR - Turchia 37
CA - Canada 28
AR - Argentina 27
PL - Polonia 25
ES - Italia 21
AT - Austria 16
MX - Messico 16
CZ - Repubblica Ceca 11
LT - Lituania 11
BD - Bangladesh 10
CO - Colombia 10
ZA - Sudafrica 10
BE - Belgio 8
CH - Svizzera 8
IQ - Iraq 8
IE - Irlanda 7
MA - Marocco 6
NO - Norvegia 6
UA - Ucraina 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
EC - Ecuador 5
PE - Perù 5
PH - Filippine 5
SA - Arabia Saudita 5
VE - Venezuela 5
DZ - Algeria 4
GR - Grecia 4
ID - Indonesia 4
PK - Pakistan 4
PY - Paraguay 4
TN - Tunisia 4
UY - Uruguay 4
UZ - Uzbekistan 4
CL - Cile 3
IL - Israele 3
KE - Kenya 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
HN - Honduras 2
IR - Iran 2
MY - Malesia 2
NP - Nepal 2
RO - Romania 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
GE - Georgia 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SI - Slovenia 1
SN - Senegal 1
Totale 5.968
Città #
Milan 263
Singapore 216
Moscow 212
Ashburn 163
Hong Kong 146
Rome 114
New York 108
San Jose 101
Dallas 87
Shanghai 78
Beijing 71
Los Angeles 52
Turin 46
Hefei 43
Lauterbourg 40
Ho Chi Minh City 35
Verona 34
Bologna 29
Hanoi 29
Lawrence 29
Princeton 29
Tokyo 28
Florence 26
Boardman 24
Genoa 24
Munich 24
São Paulo 24
Palermo 23
Bari 21
Helsinki 21
Warsaw 19
Chennai 18
Naples 18
Brooklyn 17
Orem 17
Turku 17
Santa Clara 16
Frankfurt am Main 15
Chicago 13
Montreal 13
Bolzano 12
Brescia 12
Guangzhou 12
Manchester 12
Nuremberg 12
Amsterdam 11
Azzano San Paolo 11
Catania 10
London 10
Stockholm 10
Trieste 10
Ankara 9
Da Nang 9
Vienna 9
Atlanta 8
Council Bluffs 8
Denver 8
Paris 8
The Dalles 8
Bergamo 7
Bursa 7
Dublin 7
Falconara Marittima 7
Houston 7
Istanbul 7
Lamezia Terme 7
Modena 7
Padova 7
Pavia 7
Phoenix 7
Porto Alegre 7
Buffalo 6
Cesano Boscone 6
Columbus 6
Hayamiya 6
Johannesburg 6
Lappeenranta 6
Montepulciano 6
Parma 6
Toronto 6
Venice 6
Andria 5
Barnet 5
Brussels 5
Casablanca 5
Charleston 5
Miami 5
Monza 5
Mumbai 5
Passo Fundo 5
Poplar 5
Prato 5
Pune 5
Rio de Janeiro 5
Treviso 5
Valencia 5
Arcore 4
Baghdad 4
Biên Hòa 4
Brasília 4
Totale 2.727
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 1.825
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 171
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 139
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 134
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 121
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 120
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 119
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 116
Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study 112
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 111
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 110
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 108
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 107
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 105
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 104
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment 100
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 99
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 97
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 94
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 93
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 92
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer 90
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies 90
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 90
Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1 89
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 89
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 88
Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis 88
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 82
Reply by Authors 79
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 78
The quality of life of children and adolescents with X-linked agammaglobulinemia 76
Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy 76
Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation 74
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter 72
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 70
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 64
Metastatic hormone‑sensitive prostate cancer: local treatment strategies 63
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging 62
Radioguided Surgery for Prostate Cancer 60
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter 60
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society 60
RE: Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates 60
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history 57
Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer 54
Letter - Can micro-ultrasound be the new first-choice test for patients with a suspicion of prostate cancer? 51
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy 50
The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series 44
Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes 44
Global Variation in Magnetic Resonance Imaging Quality of the Prostate 40
null 1
null 1
Totale 6.079
Categoria #
all - tutte 22.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.323


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022114 0 12 4 8 8 7 15 14 5 10 17 14
2022/2023346 78 57 22 14 14 55 24 26 15 4 24 13
2023/2024686 12 16 37 47 50 131 43 77 11 80 78 104
2024/20251.550 186 70 119 73 105 145 207 185 165 87 91 117
2025/20263.370 252 189 155 458 355 121 305 339 988 208 0 0
Totale 6.079